Takayuki Asahara spends much of his time researching Angiogenesis, Progenitor cell, Neovascularization, Immunology and Endothelium. The various areas that Takayuki Asahara examines in his Angiogenesis study include Endothelial stem cell, Vasculogenesis, Vascular endothelial growth factor A, Vascular endothelial growth factor and Pathology. His study focuses on the intersection of Endothelial stem cell and fields such as Cell biology with connections in the field of Morphogen.
Takayuki Asahara is interested in Endothelial progenitor cell, which is a field of Progenitor cell. Takayuki Asahara interconnects Receptor tyrosine kinase and Ischemia in the investigation of issues within Neovascularization. His research in Immunology intersects with topics in Cancer research and Haematopoiesis.
Takayuki Asahara mostly deals with Progenitor cell, Angiogenesis, Immunology, Vasculogenesis and Cancer research. His Progenitor cell research integrates issues from Endothelial stem cell, Neovascularization and Bone marrow. His work deals with themes such as Endocrinology and Ischemia, which intersect with Neovascularization.
His studies in Angiogenesis integrate themes in fields like Vascular endothelial growth factor A, Vascular endothelial growth factor, Endothelium and Blood vessel. His Immunology research is multidisciplinary, relying on both Ex vivo and Peripheral blood mononuclear cell. His Vasculogenesis course of study focuses on Transplantation and CD34 and Cardiology.
Takayuki Asahara mainly investigates Progenitor cell, Endothelial progenitor cell, Stem cell, Transplantation and Pathology. The study incorporates disciplines such as In vivo, Angiogenesis, Bone marrow and Ischemia in addition to Progenitor cell. His Angiogenesis research incorporates elements of Mesenchymal stem cell and Immunology.
Takayuki Asahara combines subjects such as Wound healing, Tube formation and Peripheral blood mononuclear cell with his study of Endothelial progenitor cell. Within one scientific family, Takayuki Asahara focuses on topics pertaining to Clinical trial under Transplantation, and may sometimes address concerns connected to Surgery. His Pathology study combines topics in areas such as CD34 and Regeneration.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Isolation of putative progenitor endothelial cells for angiogenesis.
Takayuki Asahara;Toyoaki Murohara;Alison Sullivan;Marcy Silver.
Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization
Takayuki Asahara;Haruchika Masuda;Tomono Takahashi;Christoph Kalka.
Circulation Research (1999)
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization.
Tomono Takahashi;Christoph Kalka;Haruchika Masuda;Donghui Chen.
Nature Medicine (1999)
Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.
Christoph Kalka;Haruchika Masuda;Tomono Takahashi;Wiltrud M. Kalka-Moll.
Proceedings of the National Academy of Sciences of the United States of America (2000)
VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells
Takayuki Asahara;Tomono Takahashi;Haruchika Masuda;Christoph Kalka.
The EMBO Journal (1999)
THERAPEUTIC POTENTIAL OF EX VIVO EXPANDED ENDOTHELIAL PROGENITOR CELLS FOR MYOCARDIAL ISCHEMIA
Atsuhiko Kawamoto;Heon-Cheol Gwon;Hideki Iwaguro;Jun-Ichi Yamaguchi.
Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic Neovascularization
Jun-ichi Yamaguchi;Kengo Fukushima Kusano;Osamu Masuo;Atsuhiko Kawamoto.
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.
T Murohara;T Asahara;M Silver;C Bauters.
Journal of Clinical Investigation (1998)
Statin Therapy Accelerates Reendothelialization A Novel Effect Involving Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells
Dirk H. Walter;Kilian Rittig;Ferdinand H. Bahlmann;Rudolf Kirchmair.
Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb
Jeffrey M Isner;Ann Pieczek;Robert Schainfeld;Richard Blair.
The Lancet (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: